Pointe Cocaine Metabolite 150 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Cocaine Metabolite Reagent Set is intended for the qualitative and semi-quantitative determination of benzoylecgonine (a cocaine metabolite) in human urine at a cutoff value of 150 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.


Product Overview

Pointe Cocaine Metabolite 150 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Cocaine Metabolite Reagent Set is intended for the qualitative and semi
Pointe Cocaine Metabolite 150 Reagent Set - 60-CC0680-1L


Device Description

A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cocaine and/or cocaine metabolites in a clinical specimen, using an enzyme immunoassay (EIA) method.


Environmental Conditions

  • Storage Environment Temperature - Degrees Celsius
    • 8.00
    • 2.00

  • Device Sizes

    No Data Available


    Device Sterilization

    Device Sterile: False

    Sterilization Prior To Use: False

    Sterilization Methods: No Data Available


    Product Codes

    Code: DIO

    Device Name: Enzyme Immunoassay, Cocaine And Cocaine Metabolites

    Device Class: 2

    Physical State: N/A

    Definition: N/A

    Submission Type ID: 1

    Review Panel: TX

    Review Code: N/A

    Technical Method: N

    Gmp Exempt Flag: N/A

    Life Sustain Support Flag: N

    Unclassified Reason: N/A

    Implant Flag: N

    Target Area: N/A

    Regulation Number: 862.3250

    Third Party Flag: Y

    Medical Specialty: TX


    Device Identifiers

    Device Id: 00811727017840

    Device Type: Primary

    DeviceId Issuing Agency: GS1

    Contains DI Number: N/A

    Package Quantity: N/A

    Package Discontinue Date: N/A

    Package Status: N/A

    Package Type: N/A


    GMDN® is a registered trademark of The GMDN Agency. All rights reserved. The information provided on this site includes data supplied by The GMDN Agency ("GMDN Content"), which is used under licence from The GMDN Agency. Any data/information suppliers who wish to extract GMDN Content from this site in order to use it as a basis for creating and supporting commercial services such as alternative categorisation, alternative GMDN Term assignment, mapping to other categorisations or ontologies, or for AI training purposes, must first obtain an appropriate licence from The GMDN Agency. No such activity is permitted without a licence. For more information on obtaining a licence, please contact The GMDN Agency (https://www.gmdnagency.org/contact-us/). None of the GMDN content constitutes any endorsement, advice, representation or warranty about any specific medical devices that may be described by such content; and no representation or warranty is made in relation to instructions for use, suitability for any application, treatment or condition, regulatory status, or any properties of a particular medical device.

    GMDN ®. © GMDN Agency 2005-.
    Educational Resources
    Videos